Milk Aflatoxin Rapid Detection Kits segmentation by type distinguishes three technology families that together shape the market’s structural composition. Lateral flow immunoassays dominate with an estimated 55 % share, offering strip‑based, visual readouts that require minimal instrumentation and enable point‑of‑care screening on farms. Within this family, single‑analyte strips address aflatoxin B1 exclusively, while multiplex strips can simultaneously detect B1, B2, and G‑type toxins, expanding utility for comprehensive safety programs. Enzyme‑linked immunosorbent assay (ELISA) kits account for roughly 30 % of sales; they provide quantitative results through microplate readers and are preferred in laboratory and regulatory settings where higher sensitivity and traceability are mandatory. ELISA formats include competitive and sandwich designs, each influencing assay time and detection limits. The remaining 15 % consists of biosensor‑based platforms, such as electrochemical or fluorescence sensors, which deliver rapid, sub‑ppb detection and integrate with digital data management systems. Although currently niche, biosensors command premium pricing and are projected to grow faster than the overall market as automation and IoT adoption increase across the dairy supply chain.
